Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026)

Updated

Idexx Laboratories' Consolidated Net Income came in at $338.41 million for Q2 2026, up 15.1% from $293.99 million a year earlier and up 21.5% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Idexx Laboratories reported Consolidated Net Income of $1.14 billion, up 15.6% year-over-year; for FY2025, it came in at $1.06 billion, up 19.3% from FY2024.

  • Consolidated Net Income has increased in each of the last three years, with a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • Going back by year, Consolidated Net Income was $887.87 million in FY2024 (+5.1%), $845.04 million in FY2023 (+24.4%), $679.09 million in FY2022 (-8.8%) and $744.84 million in FY2021 (+28.0%).
  • The Q2 2026 figure represents the highest quarterly Consolidated Net Income in data going back to Q2 2009.
  • Year-over-year, Consolidated Net Income has increased for eight consecutive quarters, with growth averaging 16.4% over the last eight quarters.
  • The fastest year-over-year change in Consolidated Net Income over five years came in Q2 2023 (growth of 69.9%), and the weakest in Q2 2022 (a decline of 34.9%).
  • Business Quant data shows IDXX's Consolidated Net Income at $278.45 million (Q1 2026), $248.19 million (Q4 2025) and $274.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 5.53 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.62 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -10.50 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -237.00 Mn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn 338.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.41 Mn
Mar 31, 2026 278.45 Mn
Dec 31, 2025 248.19 Mn
Sep 30, 2025 274.61 Mn
Jun 30, 2025 293.99 Mn
Mar 31, 2025 242.68 Mn
Dec 31, 2024 216.15 Mn
Sep 30, 2024 232.84 Mn
Jun 30, 2024 203.30 Mn
Mar 31, 2024 235.58 Mn
Dec 31, 2023 194.52 Mn
Sep 30, 2023 212.23 Mn
Jun 30, 2023 224.24 Mn
Mar 31, 2023 214.05 Mn
Dec 31, 2022 172.21 Mn
Sep 30, 2022 180.94 Mn
Jun 30, 2022 131.98 Mn
Mar 31, 2022 193.97 Mn
Dec 31, 2021 162.77 Mn
Sep 30, 2021 175.18 Mn
API Access

Idexx Laboratories Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IDXX&period=max&api_key=YOUR_API_KEY